| Association of genetic variants related to combined exposure to lower low-density lipoproteins and lower systolic blood pressure with lifetime risk of cardiovascular disease BA Ference, DL Bhatt, AL Catapano, CJ Packard, I Graham, S Kaptoge, ... Jama 322 (14), 1381-1391, 2019 | 192 | 2019 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 98 | 2022 |
| Potent lipoprotein (a) lowering following apolipoprotein (a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated … LCA Stiekema, KHM Prange, RM Hoogeveen, SL Verweij, J Kroon, ... European heart journal 41 (24), 2262-2271, 2020 | 66 | 2020 |
| Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials AJ Cupido, JJP Kastelein Cardiovascular research 116 (11), e136-e139, 2020 | 44 | 2020 |
| Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R AJ Cupido, FW Asselbergs, P Natarajan, ... British journal of clinical pharmacology 88 (6), 2875-2884, 2022 | 35 | 2022 |
| Novel lipid modifying drugs to lower LDL cholesterol AJ Cupido, LF Reeskamp, JJP Kastelein Current opinion in lipidology 28 (4), 367-373, 2017 | 32 | 2017 |
| Joint genetic inhibition of PCSK9 and CETP and the association with coronary artery disease: a factorial mendelian randomization study AJ Cupido, LF Reeskamp, AD Hingorani, C Finan, FW Asselbergs, ... JAMA cardiology 7 (9), 955-964, 2022 | 28 | 2022 |
| Gene Therapy Targeting PCSK9 JL Katzmann, AJ Cupido, U Laufs Metabolites 12 (1), 70, 2022 | 23 | 2022 |
| The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives AJ Cupido, TR Tromp, GK Hovingh Current opinion in lipidology 32 (2), 112-116, 2021 | 22 | 2021 |
| Low‐density lipoprotein cholesterol attributable cardiovascular disease risk is sex specific AJ Cupido, FW Asselbergs, AF Schmidt, GK Hovingh Journal of the American Heart Association 11 (12), e024248, 2022 | 17 | 2022 |
| Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects L Ali, AJ Cupido, M Rijkers, GK Hovingh, AG Holleboom, ... Atherosclerosis 306, 15-21, 2020 | 10 | 2020 |
| Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia TR Tromp, AJ Cupido, LF Reeskamp, ESG Stroes, GK Hovingh, ... Atherosclerosis 340, 61-67, 2022 | 8 | 2022 |
| Genetically predicted neutrophil-to-lymphocyte ratio and coronary artery disease: evidence from Mendelian randomization AJ Cupido, JM Kraaijenhof, S Burgess, FW Asselbergs, GK Hovingh, ... Circulation: Genomic and Precision Medicine 15 (1), e003553, 2022 | 7 | 2022 |
| C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study AJ Cupido, RS Petersen, AF Schmidt, M Levi, DM Cohn, LM Fijen Journal of Thrombosis and Haemostasis 21 (9), 2623-2625, 2023 | 2 | 2023 |
| Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model AJ Cupido, MH Hof, LM de Boer, R Huijgen, ESG Stroes, JJP Kastelein, ... Journal of clinical lipidology 17 (2), 236-243, 2023 | 2 | 2023 |
| Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein (a), Contribute to Monocyte Inflammation KE Dzobo, AJ Cupido, BM Mol, LCA Stiekema, M Versloot, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (3), 720-740, 2024 | 1 | 2024 |
| Gene therapy targeting PCSK9. Metabolites 2022; 12: 70 JL Katzmann, AJ Cupido, U Laufs s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Relationships and Mendelian Randomization of Gut Microbe-Derived Metabolites with Metabolic Syndrome Traits in the METSIM Cohort S Mirzaei, HA DeVon, RM Cantor, AJ Cupido, C Pan, SM Ha, ... Metabolites 14 (3), 174, 2024 | | 2024 |
| OC 09.4 C1-Inhibitor Levels and Venous Thromboembolism: Results from a Mendelian Randomization Study R Petersen, A Cupido, A Schmidt, M Levi, D Cohn, L Fijen Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| “C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study”: reply AJ Cupido, RS Petersen, AF Schmidt, M Levi, DM Cohn, LM Fijen Journal of Thrombosis and Haemostasis 21 (10), 2988-2990, 2023 | | 2023 |
GK Hovinghdept Vascular Medicine, Academic Medical CenterVerified email at amc.uva.nl
